Skip to contentHBM BIOVENTURES CAYMAN LTD — MICRUS ENDOVASCULAR CORP insider: 553 transactions · InsiderLensHBM BIOVENTURES CAYMAN LTD
- 10% owner at MICRUS ENDOVASCULAR CORP · on record since Mar 1, 2007
- 10% owner at Pacira Pharmaceuticals, Inc. · on record since Feb 10, 2011
- 10% owner at Nabriva Therapeutics AG · on record since Dec 30, 2016
- 10% owner at PTC THERAPEUTICS, INC. · on record since Jun 28, 2013
- 10% owner at Ophthotech Corp. · on record since Sep 24, 2013
- 10% owner at PROFILE TECHNOLOGIES INC · on record since Nov 5, 2014
- 10% owner at LPATH INC · on record since Oct 2, 2014
- 10% owner at ICAGEN INC · on record since Feb 3, 2005
- 10% owner at Aspreva Pharmaceuticals CORP · on record since Mar 8, 2005
- 10% owner at Werewolf Therapeutics, Inc. · on record since Apr 29, 2021
- 10% owner at IO Biotech, Inc. · on record since Nov 12, 2021
- 10% owner at Mineralys Therapeutics, Inc. · on record since Feb 16, 2023
Insider trading activity of HBM BIOVENTURES CAYMAN LTD
- Transactions on record
- 553
- since Feb 10, 2005
- Open-market buys
- 225
- $33.8M
- Open-market sells
- 286
- $66.8M
- Companies traded
- 11
- last filing Feb 16, 2023
Figures computed from official regulatory filings — methodology.
Companies where HBM BIOVENTURES CAYMAN LTD has traded
- Mineralys Therapeutics, Inc.5 tx · $5M · Feb 16, 2023
- IO Biotech, Inc.3 tx · $4.6M · Nov 12, 2021
- Werewolf Therapeutics, Inc.2 tx · May 5, 2021
- Nabriva Therapeutics AG46 tx · $6M · Sep 14, 2017
- PROFILE TECHNOLOGIES INC4 tx · $632.9K · Jun 1, 2015
- Ophthotech Corp.10 tx · $19.9M · May 15, 2014
- PTC THERAPEUTICS, INC.6 tx · $11.3M · Dec 19, 2013
- Pacira Pharmaceuticals, Inc.13 tx · $53.1M · Mar 25, 2013
- MICRUS ENDOVASCULAR CORP451 tx · $14M · Mar 4, 2010
Track record of HBM BIOVENTURES CAYMAN LTD
Statistical track record
Free- Open-market buys
- 225
- Last buy
- Feb 14, 2023
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of HBM BIOVENTURES CAYMAN LTD
Co-insiders of HBM BIOVENTURES CAYMAN LTD
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
7 tx · Mar 17, 2005
ISALY SAMUEL DNabriva Therapeutics AG +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Feb 16, 2023 | OtherD | -10,411,846 | 0.00 USD | $0 | SEC |
| Feb 16, 2023 | OtherD | -20,962,895 | 0.00 USD | $0 | SEC |
| Feb 16, 2023 | Other | 1,941,368 | — | — | SEC |
| Feb 16, 2023 | Buy | 312,500 | 16.00 USD | $5M | SEC |
| Feb 16, 2023 | Other | 964,238 | — | — | SEC |
| Nov 12, 2021 | Buy | 325,000 | 14.00 USD | $4.6M | SEC |
| Nov 12, 2021 | Other | 2,365,545 | — | — | SEC |
| Nov 12, 2021 | OtherD | -188,168 | 0.00 USD | $0 | SEC |
| May 5, 2021 | OtherD | 5,426,819 | 0.00 USD | $0 | SEC |
| May 5, 2021 | Other | 625,995 | — | — | SEC |
| Sep 14, 2017 | Sell | -3,429 | 8.52 USD | $29.2K | SEC |
| Sep 14, 2017 | Sell | -22,721 | 8.54 USD | $194K | SEC |
| Sep 14, 2017 | Sell | -10,458 | 8.63 USD | $90.3K | SEC |
| Sep 5, 2017 | Sell | -639 | 9.50 USD | $6.1K | SEC |
| Aug 9, 2017 | Sell | -17,790 | 10.50 USD | $186.8K | SEC |
| Aug 9, 2017 | Sell | -2,013 | 10.50 USD | $21.1K | SEC |
| Aug 1, 2017 | Sell | -6,585 | 10.51 USD | $69.2K | SEC |
| Jul 26, 2017 | Sell | -160 | 10.50 USD | $1.7K | SEC |
| Jul 24, 2017 | Sell | -23,445 | 10.50 USD | $246.2K | SEC |
| Jul 24, 2017 | Sell | -20,786 | 10.50 USD | $218.3K | SEC |
| Jul 21, 2017 | Sell | -23,445 | 10.50 USD | $246.2K | SEC |
| Jul 21, 2017 | Sell | -20,786 | 10.50 USD | $218.3K | SEC |
| Jul 18, 2017 | Sell | -47,460 | 10.50 USD | $498.3K | SEC |
| Jul 18, 2017 | Sell | -21,055 | 10.53 USD | $221.7K | SEC |
| Jul 18, 2017 | Sell | -1,339 | 10.50 USD | $14.1K | SEC |